Trimming the fat with an IVIG approval process

Transfusion and Apheresis Science

Volumn 46, Issue 3, 2012, Pages 349-352

  Chow, Signy ^a   Salmasi, Giselle ^a   Callum, Jeannie L ^b   Lin, Yulia ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE ENCEPHALITIS; BODY WEIGHT; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COST CONTROL; DOSE CALCULATION; DRUG APPROVAL; ENCEPHALITIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; INFANT; LETTER; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; NEWBORN HEMOLYTIC DISEASE; PAPA SYNDROME; PEMPHIGUS VULGARIS; POSTTRANSFUSION PURPURA; PRESCHOOL CHILD; PURPURA; SCHOOL CHILD; SCLEROMYXEDEMA; SUSAC SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION;

DRUG APPROVAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; OBESITY; ONTARIO; PRACTICE GUIDELINES AS TOPIC;

EID: 84860471665     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.03.030     Document Type: Letter

References (20)

1. Shehata N., Palda V., Bowen T., et al. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Trans Med Rev 2010, 24:S28-S50.
2. Robinson P., Anderson D., Brouwers M., et al. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions. Trans Med Rev 2007, 21:S3-S8.
3. Canadian Blood Services Data. (accessed on January 2012). http://www.blood.ca.
4. Callum J.L., Lin Y., Pinkerton P.H., et al. Bloody easy 3: Blood transfusions, blood alternatives and transfusion reactions: A guide to transfusion medicine 2011, Ontario Regional Blood Coordinating Network, Toronto, p 104-119. 3rd ed.
5. Hamrock D.J. Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol 2006, 6:535-542.
6. Pierce L.R., Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev 2003, 17:241-251.
7. Lin M.W., Kirkpatrick P.E., Riminton D.S. How intravenous immunoglobulin is used in clinical practice. Audits of two Sydney teaching hospitals. Intern Med J 2007, 37:308-314.
8. Constantine M.M., Thomas W., Whitman L., et al. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion 2007, 47:2072-2080.
9. Anderson D., Ali K., Blanchette V., et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Trans Med Rev 2007, 21:S9-S56.
10. Feasby T., Banwell B., Benstead T., et al. Guidelines on the use of immune globulin for neurologic conditions. Trans Med Rev 2007, 21:S57-S107.
11. Provan D., Chapel H.M., Carrock Sewell W.A., et al. Prescribing intravenous immunoglobulin: summary of Department of Health Guidelines. BMJ 2008, 337:990-992.
12. Shehata N., Palda V.A., Meyer R.M., et al. The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline. Trans Med Rev 2010, 24:S7-S27.
13. Emerson G.G., Herndon C.N., Sreih A.G. Thrombotic complications after intravenous immunoglobulin therapy in two patients. Pharmacotherapy 2002, 22:1638-1641.
14. Siegel J. Intravenous immune globulins: therapeutic, pharmaceutical, administration, and cost considerations. Pharmacy Practice News Special Edition 2009, 20-27.
15. Ontario Intravenous Immune Globulin (IVIG) Utilization Management Guidelines, November 2009.
16. Aston D.L., Lefante J., McNae A. The effect of the introduction of the criteria for clinical use of intravenous immunoglobulin (IVIg) in Australia on the supply of IVIg in Western Australia 2010, Transfusion Update, Perth.
17. Nova Scotia Provincial Blood Coordinating Program, November 2011. (accessed on January 2012). http://www.gov.ns.ca/health/nspbcp/.
18. Flegal KM, Carroll MD, Kit BK, et al. Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010. JAMA, Online First January 17, 2012.
19. Erstad B.L. Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med. 2004, 30:18-32.
20. Pai M.P., Paloucek F.P. The origin of the "ideal" body weight equations. Ann Pharmacother 2000, 34:1066-1069.